Fascia Iliaca Compartment Block and Tramadol for Analgesia in Hip Fracture

Launched by WEST CHINA HOSPITAL · Dec 6, 2024

Keywords

ClinConnect Summary

This clinical trial is studying two different methods of managing pain for patients with hip fractures. Hip fractures can be very painful and are common among older adults, so finding effective ways to relieve that pain is important for helping patients recover. The trial will compare the traditional pain medication tramadol, which can have side effects like nausea and dizziness, to a newer technique called the supra-inguinal fascia iliaca compartment block (SiFICB). This technique uses ultrasound to deliver local anesthetics that target specific nerves, potentially providing better pain relief with fewer side effects.

To be eligible for this trial, participants need to be at least 18 years old and have a confirmed hip fracture. They must also be able to give their consent to join the study. However, individuals who are allergic to tramadol or the local anesthetic used in this study, or those who cannot communicate effectively for any reason, won't be able to participate. If you join the trial, you will be evaluated on how well these two pain management methods work using a simple pain scale. This research aims to help improve pain relief methods for patients with hip fractures.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with a confirmed diagnosis of hip fracture
• • Aged \>18 years, of any gender
• • Provide signed and dated written informed consent before formal enrollment in the study.
• Exclusion Criteria:
• • Allergic to tramadol or ropivacaine
• • Unable to cooperate with the study for any reason, such as language comprehension issues, psychiatric disorders, severe hearing impairments, or communication barriers
• • Unsuitable for the trial by the investigator based on clinical judgment.